Discontinuity of social support among US adults with cognitive impairment before and after the confirmed diagnosis of ...

Progression-free survival was significantly greater in retifanlimab compared to placebo. 2. Serious and grade 3 or more adverse events were more common in the retifanlimab group. Evidence Rating Level ...